Dynamics of Glycoprotein Charge in the Evolutionary History of Human Influenza

Background Influenza viruses show a significant capacity to evade host immunity; this is manifest both as large occasional jumps in the antigenic phenotype of viral surface molecules and in gradual antigenic changes leading to annual influenza epidemics in humans. Recent mouse studies show that avidity for host cells can play an important role in polyclonal antibody escape, and further that electrostatic charge of the hemagglutinin glycoprotein can contribute to such avidity. Methodology/Principal Findings We test the role of glycoprotein charge on sequence data from the three major subtypes of influenza A in humans, using a simple method of calculating net glycoprotein charge. Of all subtypes, H3N2 in humans shows a striking pattern of increasing positive charge since its introduction in 1968. Notably, this trend applies to both hemagglutinin and neuraminidase glycoproteins. In the late 1980s hemagglutinin charge reached a plateau, while neuraminidase charge started to decline. We identify key groups of amino acid sites involved in this charge trend. Conclusions/Significance To our knowledge these are the first indications that, for human H3N2, net glycoprotein charge covaries strongly with antigenic drift on a global scale. Further work is needed to elucidate how such charge interacts with other immune escape mechanisms, such as glycosylation, and we discuss important questions arising for future study.

[1]  J. Goudsmit,et al.  Maintenance of syncytium-inducing phenotype of HIV type 1 is associated with positively charged residues in the HIV type 1 gp120 V2 domain without fixed positions, elongation, or relocated N-linked glycosylation sites. , 1995, AIDS research and human retroviruses.

[2]  R. Dwek,et al.  The Glycosylation of the Influenza A Virus Hemagglutinin by Mammalian Cells , 1997, The Journal of Biological Chemistry.

[3]  J. R. Textbook of Organic Chemistry , 1939, Nature.

[4]  R. Webster,et al.  H3N2 Influenza Virus Transmission from Swine to Turkeys, United States , 2004, Emerging infectious diseases.

[5]  I. Wilson,et al.  Structural basis of immune recognition of influenza virus hemagglutinin. , 1990, Annual review of immunology.

[6]  E. Holmes,et al.  The evolution of epidemic influenza , 2007, Nature Reviews Genetics.

[7]  B. G. Hale,et al.  The multifunctional NS1 protein of influenza A viruses. , 2008, The Journal of general virology.

[8]  Rahul Raman,et al.  Hemagglutinin Receptor Binding Avidity Drives Influenza A Virus Antigenic Drift , 2009, Science.

[9]  N. Ferguson,et al.  Ecological and immunological determinants of influenza evolution , 2003, Nature.

[10]  C. W. Lee,et al.  Isolation and Characterization of H3N2 Influenza A Virus from Turkeys , 2005, Avian diseases.

[11]  C. Bender,et al.  Differences in the biological phenotype of low-yielding (L) and high-yielding (H) variants of swine influenza virus A/NJ/11/76 are associated with their different receptor-binding activity. , 1998, Virology.

[12]  H. Klenk,et al.  N-Glycans attached to the stem domain of haemagglutinin efficiently regulate influenza A virus replication. , 2002, The Journal of general virology.

[13]  I. Schulze Effects of glycosylation on the properties and functions of influenza virus hemagglutinin. , 1997, The Journal of infectious diseases.

[14]  W G Laver,et al.  Molecular mechanisms of variation in influenza viruses , 1982, Nature.

[15]  Kimberly B. Ulett,et al.  N-Linked Glycosylation Attenuates H3N2 Influenza Viruses , 2007, Journal of Virology.

[16]  Bette Korber,et al.  Tracking global patterns of N-linked glycosylation site variation in highly variable viral glycoproteins: HIV, SIV, and HCV envelopes and influenza hemagglutinin. , 2004, Glycobiology.

[17]  A. Lapedes,et al.  Mapping the Antigenic and Genetic Evolution of Influenza Virus , 2004, Science.

[18]  Temple F. Smith,et al.  Darwinian selection for sites of Asn-linked glycosylation in phylogenetically disparate eukaryotes and viruses , 2009, Proceedings of the National Academy of Sciences.

[19]  O. Pybus,et al.  Unifying the Epidemiological and Evolutionary Dynamics of Pathogens , 2004, Science.

[20]  Richard A. Goldstein,et al.  Changing Selective Pressure during Antigenic Changes in Human Influenza H3 , 2008, PLoS pathogens.

[21]  R. Bansal A Textbook of Organic Chemistry , 2007 .

[22]  A Flahault,et al.  Influenza vaccine: the challenge of antigenic drift. , 2007, Vaccine.

[23]  C. Viboud,et al.  Explorer The genomic and epidemiological dynamics of human influenza A virus , 2016 .

[24]  E. Holmes RNA virus genomics: a world of possibilities. , 2009, The Journal of clinical investigation.

[25]  Kay-Hooi Khoo,et al.  Glycans on influenza hemagglutinin affect receptor binding and immune response , 2009, Proceedings of the National Academy of Sciences.